| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 127,737 | 118,463 | 113,476 | 126,477 | | Cost of Revenue | 93,782 | 89,330 | 86,325 | 104,543 | | | Gross Profit | 33,955 | 29,133 | 27,151 | 21,934 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 11,919 | 12,440 | 12,751 | 13,766 | | Non Recurring | 524 | 38,552 | 2,782 | 81,210 | | Others |
-
| 20 | 30 | 31 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,512 | (21,879) | 11,588 | (73,073) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 160 | 65 | 74 | (22) | | Earnings Before Interest And Taxes | 21,672 | (21,814) | 11,662 | (73,095) | | Interest Expense | 318 | 349 | 258 | 160 | | Income Before Tax | 21,354 | (22,163) | 11,404 | (73,255) | | Income Tax Expense | 7,919 | (5,565) | 4,220 | (20,357) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 13,435 | (16,598) | 7,184 | (52,898) | | | Non-recurring Events | | Discontinued Operations |
-
| 42 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,435 | (16,556) | 7,184 | (52,898) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $13,435 | ($16,556) | $7,184 | ($52,898) |
|
0.01% Nasdaq 0.00%
Income Statement
